Page 25 - 2020 ARE eGuide for Clinical at Nonhospital Sites
P. 25
2020 Annual Required Education
Anticoagulation Therapy:
Anticoagulation is a high-risk treatment, which commonly leads to adverse
drug events due to the complexity of dosing these medications, monitoring their
effects, and ensuring patient compliance with outpatient therapy.
The use of standardized
practices that include patient
involvement can reduce the risk
of adverse drug events
associated with the use of heparin
(unfractionated), low molecular
weight heparin (LMWH), warfarin,
and other anticoagulants.
Patient/family education must
include the importance of follow-
up monitoring, compliance issues,
dietary restrictions, and potential
for adverse drug reactions and
interactions.
